© 2017 by Polar Cryotherapy LLC

NOTE:   These statements have not been evaluated by the Food and Drug Administration. This service and product are not intended to diagnose, treat, cure, or prevent any disease.  No claims as to the effectiveness of the ARRC LED EDGE are made by Polar Cryotherapy.  All of the cited research is based on studies posted from the NIH Pubmed website. The purpose of highlighting these studies is to eliminate manufacturer skewed claims and biases.  This is research only and not meant to be specific claims for the ARRC LED.

The benefits of PBM Therapy are backed by over 400 randomised, controlled trials  and in over 4,000 laboratory studies.

PBM Therapy is used in thousands of clinics, hospitals and elite sports institutions in over 70 nations.

PhotoBioModulation Research

Section 2.8.   Downstream tissue response

There have been a large number of both animal model and clinical studies that demonstrated highly beneficial LLLT effects on a variety of diseases, injuries, and has been widely used in both chronic and acute conditions (see Figure 7). LLLT may enhance neovascularisation, promote angiogenesis and increase collagen synthesis to promote healing of acute (Hopkins et al. 2004) and chronic wounds (Yu et al. 1997). LLLT provided acceleration of cutaneous wound healing in rats with a biphasic dose response favoring lower doses (Corazza et al. 2007). LLLT can also stimulate healing of deeper structures such as nerves (Gigo-Benato et al. 2004), tendons (Fillipin et al. 2005), cartilage (Morrone et al. 2000), bones (Weber et al. 2006) and even internal organs (Shao et al. 2005). LLLT can reduce pain (Bjordal et al. 2006a), inflammation (Bjordal et al. 2006b) and swelling (Carati et al. 2003) caused by injuries, degenerative diseases or autoimmune diseases. Oron reported beneficial effect of LLLT on repair processes after injury or ischemia in skeletal and heart muscles in multiple animal models in vivo (Ad and Oron 2001Oron et al. 2001aOron et al. 2001bYaakobi et al. 2001). LLLT has been used to mitigate damage after strokes (in both animals (Lapchak et al. 2008) and humans (Lampl et al. 2007)), after traumatic brain injury (Oron et al. 2007) and after spinal cord injury (Wu et al. 2009).


Beneficial tissue effects of LLLT can include almost all the tissues and organs of the body.

Studies on Athletes:

CONCLUSIONS: Based on existing evidence, it is argued that PBM therapy can raise the standard of care and improve the quality of life of patients for a fraction of the cost of many current approaches. PBM therapy can, therefore,benefit large, vulnerable population groups, including the elderly and the poor, while having a major impact on medical practice and public finances.

With the predicted epidemic of chronic pain in developed countries, it is imperative to validate cost-effective and safe techniques for managing painful conditions which would allow people to live active and productive lives. Moreover the acceptance of LLLT (which is currently being used by many specialties around the world) into the armamentarium of the American health care provider would allow for additional treatment options for patients. A new cost-effective therapy for pain could elevate quality of life while reducing financial strains.



  • Black Facebook Icon
  • Black Instagram Icon
  • Black Twitter Icon